Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular Interventions
Saurabhi Samant(University of Nebraska Medical Center), Yiannis S. Chatzizisis(University of Miami), Francesco Migliavacca(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), John R. Windle(University of Nebraska Medical Center), Deepak L. Bhatt(Mount Sinai Hospital), Janaki Makadia(University of Nebraska Medical Center), Usama M. Oguz(University of Miami), Peter Mortier, Yoshinobu Murasato(National Hospital Organization), Habib Samady(Emory University), W.A. Glass(University of Nebraska Medical Center), Andrew D. Bicek(Boston Scientific (United States)), Farouc A. Jaffer(Massachusetts General Hospital), Alexandra Lansky(Yale University), Eric J. Velazquez(Yale University), Paul A. Iaizzo(Minneapolis Heart Institute Foundation), Gabriele Dubini(Politecnico di Milano), Pierre Elias(Columbia University Irving Medical Center), Goran Stanković(University of Belgrade), Carlos Mena‐Hurtado(Mount Sinai Hospital), John F. LaDisa(Marquette University), Nihar R. Desai(Princess Margaret Cancer Centre), George Dangas(Mount Sinai Hospital), Claudio Chiastra(Politecnico di Torino), Daniel R. Anderson(University of Nebraska Medical Center), Patrick W. Serruys(Erasmus MC), Timothy Mickley(Boston Scientific (United States)), Behram Khan(University of Miami), Anastasios Panagopoulos(Emory University), Nick E.J. West(Papworth Hospital), Ghassan S. Kassab(California Medical Innovations Institute), Yves Louvard(Hôpital Privé Jacques Cartier), Wei Wu(University of Miami), James E. Tcheng(Duke University), Pamela J. Boyers(University of Nebraska Medical Center), Muhammad Fayaz(Sejong University), Francesco Burzotta(Agostino Gemelli University Polyclinic), Shijia Zhao(University of Miami), Dawn Abbott(Brown University), Jules Joel Bakhos(University of Miami), Jeffrey P. Gold(University of Nebraska Medical Center), Akshat Banga(University of Miami), Jens Flensted Lassen(University of Southern Denmark), Jason Fontana(Medtronic (United States)), Emmanouil S. Brilakis(Minneapolis Heart Institute Foundation)
Cited by 89
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k